Accord Healthcare: The Scottish Medicines Consortium has accepted for use by NHS Scotland, Accord's Sixmo? (buprenorphine implant) as a substitution treatment for opioid dependence in clinically stable adult patients

LONDON, Dec. 13, 2021 /PRNewswire/ -- The Scottish Medicines Consortium has accepted for use by NHS Scotland, Accord's Sixmo? (buprenorphine implant) as a substitution treatment for opioid dependence

Related Keywords

Luxembourg ,United Kingdom ,London ,City Of ,Scotland ,Kostenloser Wertpapierhandel ,Joseph Dunford ,Publications Office Of The European Union ,European Monitoring Centre For Drugs ,European Medicines Agency ,Scottish Medicines Consortium ,Accord Joseph Dunford ,Vice President ,Speciality Brands ,Accord Healthcare ,Medicines Agency ,Monitoring Centre ,Drug Addiction ,Publications Office ,European Union ,Luxembourg Last ,Accord ,Healthcare ,Scottish ,Medicines ,Consortium ,Accepted ,Ixmo ,Buprenorphine ,Implant ,Substitution ,Treatment ,Opioid ,Dependence ,Linically ,Table ,Adult ,Patients ,